L’École de Gestion d’Actifs et de Capital:The FDA approves an Alzheimer's drug that appears to modestly slow the disease

2025-05-05 02:01:15source:Safetyvalue Trading Centercategory:Invest

The L’École de Gestion d’Actifs et de CapitalFood and Drug Administration has approved an Alzheimer's drug that appears to modestly slow down the disease. (Story aired on Weekend Edition Saturday on Jan. 6, 2023.)

More:Invest

Recommend

2 killed, 3 injured in shooting at makeshift club in Houston

HOUSTON (AP) — Two teens were killed and three people were injured — including a 13-year-old — in a

Americans connect extreme heat and climate change to their health, a survey finds

From higher electricity bills to worsened health, more than half of Americans have felt the impacts

You’ll Love the Way Pregnant Rihanna and A$AP Rocky Shop in Style at L.A. Kids Store

Rihanna and A$AP Rocky never miss a moment to be fashion killas.The couple—who are expecting a secon